N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143108 |
| CAS No | NA |
| Mol.F. | C12H27N3O4 |
| Mol.Wt. | 277.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143109 |
| CAS No | NA |
| Mol.F. | C12H18N2O2 |
| Mol.Wt. | 222.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143110 |
| CAS No | NA |
| Mol.F. | C4H7N9O |
| Mol.Wt. | 197.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143111 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143112 |
| CAS No | NA |
| Mol.F. | C2H5N5O3 |
| Mol.Wt. | 147.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143113 |
| CAS No | NA |
| Mol.F. | C4H8N6O |
| Mol.Wt. | 154.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143114 |
| CAS No | NA |
| Mol.F. | C7H12N4O2 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143115 |
| CAS No | NA |
| Mol.F. | C20H21FN4O5 |
| Mol.Wt. | 416.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143116 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143117 |
| CAS No | NA |
| Mol.F. | C26H22N4O5 |
| Mol.Wt. | 470.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143118 |
| CAS No | NA |
| Mol.F. | C30H30N6O5 |
| Mol.Wt. | 554.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143119 |
| CAS No | NA |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143120 |
| CAS No | NA |
| Mol.F. | C28H23FN4O6 |
| Mol.Wt. | 530.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143121 |
| CAS No | NA |
| Mol.F. | C15H16N2O7 |
| Mol.Wt. | 336.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143122 |
| CAS No | NA |
| Mol.F. | C23H18FN3O4 |
| Mol.Wt. | 419.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143123 |
| CAS No | NA |
| Mol.F. | C22H19N3O7 |
| Mol.Wt. | 437.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |